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Abstract
Although recent evidence indicates that several chemokines and defensins, well-known as
inflammatory mediators, are expressed in the male and female reproductive tracts, the location and
functional significance of chemokine networks in sperm physiology and sperm reproductive tract
interactions are poorly understood. To address this deficiency in our knowledge, we examined the
expression and function in sperm of CCR6, a receptor common to several chemoattractant
peptides, and screened several reproductive tract fluids for the presence of specific ligands. CCR6
protein is present in mouse and human sperm and mainly localized in the sperm tail with other
minor patterns in sperm from mice (neck and acrosomal region) and men (neck and midpiece
regions). As expected from the protein immunoblotting and immunofluorescence results, mouse
Ccr6 mRNA is expressed in the testis. Furthermore, the Defb29 mRNA encoding the CCR6
ligand, β-defensin DEFB29, is expressed at high levels in the epididymis. As determined by
protein chip analysis, several chemokines (including some that act through CCR6, such as CCL20/
MIP-3α (formerly Macrophage Inflammatory Protein 3α) and protein hormones were present in
human follicular fluid, endometrial secretions, and seminal plasma. In functional chemotaxis
assays, capacitated human sperm exhibited a directional movement towards CCL20, and displayed
modifications in motility parameters. Our data indicate that chemokine ligand/receptor interactions
in the male and female genital tracts promote sperm motility and chemotaxis under non-
inflammatory conditions. Therefore, some of the physiological reactions mediated by CCR6
ligands in male reproduction extend beyond a pro-inflammatory response and might find
application in clinical reproduction and/or contraception.
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Introduction
A mammalian spermatozoon must locate the female gamete and deliver its genetic material
to generate a new individual. The interaction of motile sperm with the oocyte – both at a
distance and through physical interaction – represents a series of integrated processes
designed to deliver sperm with optimal fertilizing potential to the site of fertilization. Sperm
movement patterns appear to depend on external regulatory factors secreted by the oocyte or
its surrounding cells that influence sperm motility (chemokinesis) and chemotaxis, which
would optimize gamete interactions (Eisenbach, 1999; Eisenbach and Giojalas, 2006;
Kaupp, 2012). The development of the fertilization-competent state occurs through an
incompletely understood process called “capacitation,” which refers to the physiological
changes that render spermatozoa competent to fertilize an egg (Visconti et al., 1998, 2011).
Precontact communication by chemotaxis has been demonstrated between gametes in pig,
rabbit, human, and mice (Cohen-Dayag et al., 1995; Lee et al., 1994; Sliwa, 1995; Spehr et
al., 2003; Teves et al., 2010). The involvement of different molecules in chemokinesis and
in the chemotactic attraction of human sperm to the oocyte is a fascinating and evolving
concept.
The substances secreted by the male and female reproductive tracts that influence sperm
behavior, physiology, and viability are coming to light, as techniques to screen for various
substances in biological fluids are developed and improved. For instance, human seminal
plasma contains a variety of inflammatory cytokines, which are thought to confer a survival
advantage to spermatozoa within the female genital tract (Denison et al., 1999).
Chemokines, a family of chemotactic cytokines produced by a wide variety of cell types,
have the ability to attract cells in response to the activation of specific cell surface receptors
(Baggiolini, 1998). Several types of mammalian β-defensins have also been found in male
reproductive tissues (Conejo-Garcia et al., 2004; Li et al., 2001; Rodríguez-Jiménez et al.,
2003). Multiple β-defensins have been independently identified as functional ligands for the
chemokine receptor CCR6 (Conejo-Garcia et al., 2004; Röhrl et al., 2010a; Taylor et al.,
2009; Yang et al., 1999) and, more recently, for CCR2 (Röhrl et al., 2010b).
Chemokine receptors belong to the superfamily of G protein-coupled receptors (GPCR).
These canonical receptors have seven transmembrane sequences of 20-25 hydrophobic
residues that form α-helices within the plasma membrane, an extracellular N-terminus, three
extracellular loops, three intracellular loops, and a C-terminal cytoplasmic tail. These
receptors transmit information to the cell about the presence of chemokine gradients in the
extracellular environment. They are named depending on the structure of their ligand (CXC,
CC or CX3C). The binding of a chemokine or chemoattractant peptide such as a β-defensin
to its cognate receptor is followed by the involvement of heterotrimeric G proteins (Reif and
Cantrell, 1998; Ward and Westwick, 1998) and the triggering of pathways involving
intracellular second messengers such as cAMP and calcium.
The molecular mechanisms involved in the chemoattraction of specific sperm subsets prior
to fertilization remain unknown. Moreover, the location and functional significance of
chemokines and chemokine receptors in sperm physiology and male and female genital
tracts are poorly understood. It is clear that sperm motility characteristics are modified in
response to changes in the microenvironment as the sperm move through the male and
female genital tracts. Furthermore, human seminal plasma has potent anti-inflammatory
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properties, which are thought to confer a survival advantage to spermatozoa within the
hostile female genital tract (Kelly, 1995, Robertson et al 2007).
In this study, we identified the presence of receptor CCR6, and its chemoattractant ligands
(CCL20 and β-defensins) in human and mouse spermatozoa as well as in the gamete
microenvironment during capacitation. We also show that mouse Defb29, previously
characterized by one of us (Conejo-Garcia et al., 2004), is highly expressed in the cauda
epididymis. Our results provide evidence that, in addition to their role in inflammation,
certain β-defensins and chemokines have specific functions through ligand/receptor
interactions in sperm motility and chemotaxis acting in the male and female reproductive
tracts.
Materials and Methods
Collection and analysis of human semen samples
Human semen samples were obtained by masturbation from healthy donors with proven
fertility after 2-5 days of abstinence. The samples were collected in sterile containers and
evaluated within 1 h after ejaculation following World Health Organization guidelines
(World Health Organization, 2010). Briefly, semen analysis included evaluation of volume,
concentration, motility, morphology, viscosity, and leukocyte count. Semen parameters were
consistently superior to WHO reference values, and leukospermia was not found in any of
the analyzed samples. Informed consent to use semen samples was obtained from each
participant in this study and collection of semen was approved by the University of
Pennsylvania Institutional Review Board. To prepare seminal plasma, liquefied semen
samples were first centrifuged at 1,000 × g for 5 min, after which the supernatants were re-
centrifuged at 10,000 × g for 15 min to remove cellular elements and debris. After
centrifugation, the seminal plasma was collected and stored at −80°C until used. For
capacitation, sperm samples were prepared as previously described (Caballero-Campo et al.,
2006).
Follicular and endometrial fluids
Human follicular fluid (FF) and endometrial fluid samples were obtained from women
whose routine infertility examination revealed no abnormal findings, and who were
undergoing transvaginal follicular aspiration for IVF due to male infertility as previously
described (Simón et al., 1996). Fluids were collected under an Institutional Review Board
protocol for samples that would otherwise be discarded. No patient identifiers were used in
the sample collection nor was specific patient information received. Women with
endometriosis, polycystic ovary syndrome, or infectious diseases were excluded from this
study. The FF obtained from follicles of >16 mm diameter were pooled, immediately
centrifuged for 5 min at 1,500 × g, and then filtered through a 0.5 μm disc filter to remove
cells and debris. The filtrates were aliquoted and stored at −20°C until used.
Mouse samples
Adult (>12 weeks old) CD-1 male mice were purchased from Charles River Laboratories,
Inc. (Wilmington, MA). Mice were used in accordance with the International Guiding
Principles for Biomedical Research Involving Animals as promulgated by the Society for
the Study of Reproduction, and research protocols involving animals were approved by the
University of Pennsylvania Institutional Animal Care and Use Committee.
Indirect immunofluorescence (IIF) and flow cytometry
Mouse cauda epididymal sperm and ejaculated human sperm were analyzed by indirect
immunofluorescence (Kim et al., 2001) and flow cytometry (Griffiths et al., 2008).
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Noncapacitated and capacitated mouse and human sperm samples were washed for 5 min at
300 × g, resuspended in PBS, and attached to poly-L-lysine-coated slides. Spermatozoa were
fixed (4% paraformaldehyde in PBS) for 15 min. After washing in PBS, slides were blocked
with PBS containing 600 μg/ml BSA for 30 min at room temperature. The slides were then
incubated for 1 h at 37°C in a humidified chamber with primary antibody (mouse anti-
human CCR6 catalog number MAB195 or rat anti-mouse CCR6 catalog number MAB590,
R&D Systems, Minneapolis, MN) diluted in blocking buffer 1:100. Slides incubated without
first antibody in 10% normal goat serum were used as negative controls. After three washes
in PBS, the slides were incubated in blocking buffer containing FITC-goat anti-mouse IgG
(1:5000) and FITC-goat anti-rat IgG (1:5000) (Santa Cruz Biotech) for 1 h. Following
several washes in PBS, sperm were examined by phase contrast/fluorescence microscopy
(modified from Kim et al. (2001)). Analysis by flow cytometry of cells labeled with the
antibodies was carried out as described by Lasso et al. (1994) with a FACSCalibur flow
cytometer with CellQuest 3.2.1fl software (Becton Dickinson).
Immunoblotting
Mouse and human sperm proteins were separated by SDS-PAGE according to the method of
Laemmli (1970) and transferred to Immobilon (PVDF) transfer membranes (Towbin et al.,
1979; Turner et al., 1999, 2001). Blots were blocked in 5% non-fat dry milk in Tween-Tris
buffered saline (TTBS) and incubated overnight at 4°C with primary antibody (goat anti-
human/mouse CCR6, Catalog number C10129, Capralogics, Gilbertville, MA) in blocking
buffer 1:500. Blots were then treated with secondary antibody (horseradish peroxidase-
conjugated chicken anti-goat IgG, Santa Cruz Biotechnology, Santa Cruz, CA) in TTBS
buffer (1:2000) for 1 h at room temperature, and developed using enhanced
chemiluminescence (ECL) substrate (Pierce). Bound antibody was visualized by
chemiluminescence exposure of X-ray film. In some experiments blots were developed
using enhanced chemifluorescence (ECL Plus RPN2132) substrate (Amersham), utilizing a
novel acridine-based chemistry and horseradish peroxidase to generate a light signal and
also a stable fluorescent product that can be visualized by chemifluorescence densitometry
(blue laser) on a Storm 860 phosphoimager (Molecular Dynamics. Sunnyvale, CA).
Quantification of mRNA by real-time RT-PCR
Samples from mouse testes and the different parts of the epididymis (caput, corpus, cauda)
were used to study the expression of Defb29 (GenBank accession number AF515626)
compared to other male and female tissues by real-time quantitative RT-PCR (Conejo-
Garcia et al., 2004) Levels of mRNA encoding various gene products were determined by
real-time RT-PCR as previously described by García et al. (2001). Briefly, after RNA
extraction, complementary DNA was generated by reverse transcription with TaqMan® and
SYBR® Green One-Step Real-Time RT-PCR Master Mix (Applied Biosystems, Foster
City, CA). Complementary DNA primers were designed using Primer3 software (http://
frodo.wi.mit.edu/). The primers used were previously designed as Defb29: (forward: 5’–
CTG ATC CTG GTT GAC GAG ACC–3’; reverse: 5’–CTG GTA AAG CTC ACA CGC
AAT C–3’) and Gapdh: (forward: 5’–CCT GCA CCA CCA ACT GCT TA–3’; reverse: 5’–
CAT GAG TCC TTC CAC GAT ACC A–3’) (Conejo-Garcia et al., 2004; Cubillos-Ruiz et
al., 2009). For Ccr6, the primers were (forward: 5’–GGA CTG AGA GCC CTG GAA AG–
3’; reverse: 5’–CTT GAA TGG CAG ACA CTC ACA GT–3’). Standard curves for Defb29,
Ccr6, and Gapdh were constructed. Two microliters of RT product were used for real-time
PCR. The amplification reaction (25 μl) contained RT product, forward primer, and reverse
primer. Reactions were performed with previously established thermal cycling conditions in
the ABI 7700 Sequence Detector (Applied Biosystems). Collection and analysis of data
were performed with ABI 7700 sequence detector software.
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Detection of chemokines in human reproductive fluids
To evaluate the presence of chemokines in seminal plasma (4 specimens), follicular fluid (3
specimens), and endometrial fluid (3 specimens), samples were analyzed with the RayBio
Human Cytokine Antibody Array I and IV membranes (RayBiotech, Norcross GA), which
allow the detection of 42 and 38 different cytokines and chemokines, respectively.
Membranes were analyzed following the manufacturer’s instructions. Briefly, membranes
with pre-spotted capture antibodies were incubated with samples for 2 h at room
temperature. Chemokines were detected by incubation with biotinylated detection antibodies
for another 2 h at room temperature. Following addition of horseradish peroxidase-
conjugated streptavidin and overnight incubation at 4°C, signals were revealed by ECL and
(ECL Plus RPN2132 substrate Amersham). ECL Plus can be visualized by
chemifluorescence densitometry (blue laser) on a Storm 860 phosphoimager (Molecular
Dynamics. Sunnyvale, CA). Positive controls included in the blot were used to normalize
the results from different membranes.
Evaluation of human sperm motility changes after treatment with ligands for CCR6
To demonstrate a functional role for CCR6 in human sperm, we investigated the dynamic
response of capacitated spermatozoa to treatment with several CCR6 ligands. To perform an
objective evaluation, computer assisted sperm analysis (CASA; IVOS system version 12,
Hamilton-Thorne Biosciences, Beverly, MA) was performed to assess changes in motility
patterns after exposure to CCR6 ligands. The kinetic parameters classify sperm movement
into different types of progressive motility as “rapid” or “slow” according to the CASA
settings, and as “hyperactivated” motility using the criteria defined previously (Burkman,
1991; Caballero-Campo et al., 2006). Capacitated human sperm samples were incubated
with the ligands for CCR6 to assess effects on sperm motility kinetics and chemotaxis. After
capacitation, 10 million cells per ml were incubated with increasing concentrations (0, 10,
100, 1000 pg/ml) (Isobe et al., 2002) of recombinant human CCL20 (R&D Systems,
Minneapolis, MN), recombinant human DEFB4A (also known as DEFB2, formerly hBD-2;
Catalog No. HBD25-R from Alpha Diagnostics International, San Antonio, TX) (Hoover et
al., 2002; Pérez-Cañadillas et al., 2001) and human DEFB103A (also known as DEFB3,
formerly hBD-3; Catalog No. HBD37-R from Alpha Diagnostics International) (García et
al., 2001) proteins diluted in HTF medium at 37°C and 5% CO2. As a control, several
dilutions of FF were used. At the end of the incubation times, manual motility assessments
(World Health Organization, 2010) were performed on sperm from different concentration
treatments. The 1,000 pg/ml point was chosen as the working concentration for the
following motility assay experiments. The motility patterns of capacitated sperm were
examined with a double sperm motility and chemotactic evaluation approach, after treatment
with ligands for CCR6. The analysis of sperm motility parameters was performed using
CASA. For this evaluation, 5 μl aliquots of treated or control sperm samples were placed in
a 20 μm depth standard count analysis chamber (Leja Products, Nieuw-Vennep, The
Netherlands) that had been preheated at 37°C, and analyzed using the CASA system with
settings according to the manufacturer’s instructions. For every sample, approximately 10
randomly selected fields were evaluated for a minimum total of 300 sperm. Average values
were obtained for sperm motion parameters such as: curvilinear velocity (VCL), straight-
line velocity (VSL), average path velocity (VAP), amplitude of lateral head displacement
(ALH), linearity (LIN=VSL/VCL), and straightness (STR=VSL/VAP). Progressive motile
sperm were defined by values of VAP > 20 μm/s and STR > 80%. Rapid or slow motile
sperm cells were classified according to the CASA standard cutoff values for VAP and VSL.
Slow cells were defined as cells with either of the following attributes: VAP < 20 μm/s or
VSL < 30 μm/s. In addition, we also analyzed individual parameters and recorded sperm
tracks (Caballero-Campo et al., 2006).
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Chemotaxis
To investigate the chemotactic effect of CCL20, the percentage of chemotactic sperm after
the different treatments was analyzed by the directionality-based method described by Fabro
et al., (2002), with minor modifications, using the Zigmond chemotaxis chambers
(Zigmond, 1977). These devices, kindly provided by Dr. Sally Zigmond of the University of
Pennsylvania, consist of two wells separated by a partition wall and closed with a cover slip.
As a control for human sperm chemotaxis, we used follicular fluid, which is well-established
as a sperm chemoattractant (Cohen-Dayag et al., 1995; Eisenbach and Tur-Kaspa, 1999;
Makler et al., 1992; Ralt et al., 1991; Villanueva-Diaz et al., 1990). Briefly, the system
allows the formation of a concentration gradient of the chemoattractant test substance
between both compartments. The spermatozoa are put in one well, whereas the testing well
is filled with FF or a CCR6 ligand. The movement of the cells in the partition wall
separating the wells is recorded at 10X magnification. Our video microscopy system
consists of an inverted microscope Nikon TE2000 equipped with a Princeton Instruments
MicroMax CCD camera with a time-lapse video recorder (Roger Scientific, Trenton NJ)
(Buffone et al., 2009). The system allows the formation of a concentration gradient from the
one well, filled with the chemoattactrant (CCL20), to the other well, filled with spermatozoa
(capacitated sperm). Sperm cells were recorded onto the partition wall (in the middle of the
two wells) at using a 10X objective for 10-15 minutes. As controls for human sperm
chemotaxis, we used FF which is a well-established sperm chemoattractant (Eisenbach and
Tur-Kaspa, 1999), and non-capacitated human sperm cells as negative control, only
capacitated cells are chemotactically responsive (Cohen-Dayag et al., 1995). In each
recording, the sperm tracks where analyzed semiautomatically (Fabro et al., 2002) for 5-10
minutes after the distribution of the cells was stable. Defining X-axis as the direction of the
gradient, the tracks were analyzed as the percentage of the cells traveling longer distance in
the direction of the chemoattractant gradient than in the gradient-less direction,
perpendicular defined by Y-axis. We evaluated the chemotactic sperm tracks using a grid, in
by the means of the percentage of cells having ΔX/ΔY>1 (± SD), apart from the sperm speed
and pattern of movement (Fabro et al., 2002). The results shown in Figure 7 correspond to 4
independent experiments from two donors. In addition, under the same CCL20 and FF
treatment conditions as for sperm motility evaluation, we analyzed individual motility
parameters and recorded sperm tracks (Caballero-Campo et al., 2006). All data were
transferred and processed in Excel files prior to statistical analysis.
Statistical analysis
The Statistical Package for the Social Science (SPSS Inc., Chicago, IL) was used for
statistical analysis. The analysis of variance (ANOVA) for multiple comparisons was carried
out between groups and p<0.05 was considered statistically significant.
Results
Reproductive fluids contain multiple chemoattractant peptides
To define the presence of chemokines in reproductive fluids, we performed protein arrays
using human seminal plasma, endometrial fluid, and follicular fluid. An unexpectedly high
number of chemokines were identified in fluids from both the female and male genital tracts.
These included the specific CCR6 ligand CCL20, as well as CXCL8 (interleukin 8),
CX3CL1 (fractalkine), and CCL2 (monocyte chemotactic protein 1), traditionally associated
with the recruitment of multiple immune cell populations. In addition, CCL5 (RANTES)
was found in follicular fluid, but not in seminal plasma nor endometrial fluid (Figure 1).
Relevant expressions patterns for IL-8, CCL2/MCP-1, CCL5/Rantes, CXC3CL1/
Fraktalkine, and CCL20/MIP-3α are summarized in Table 1.
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In complementary studies in mice, we next determined the expression of the corresponding
receptors in a variety of tissues, and we found that Ccr6 mRNA is expressed at high levels in
the testis but it was undetectable in samples from the uterus (Figure 2A). To define the
expression of alternative CCR6 ligands in reproductive tissues, we focused on the unknown
expression pattern of the Defb29 mRNA encoding mouse DEFB29, a proven CCR6 ligand
and the counterpart of human DEFB116 (Conejo-Garcia et al., 2004). Surprisingly, the
highest level of Defb29 expression was found in the cauda epididymis, relative to any other
tissue (Figure 2B). Defb29 mRNA was also expressed by other regions of the epididymis at
significantly lower levels.
CCR6 is localized in flagella of mouse and human spermatozoa
Because Ccr6 mRNA is expressed in the male mouse genital tract, but not at detectable
levels in uterine tissue, we next aimed to define the presence and localization of the CCR6
protein in mouse and human sperm. Indirect immunofluorescence revealed that CCR6 was
clearly detected in human sperm and was mainly localized in the tail and in the post-
acrosomal region (Figure 3A). CCR6 was also found in the midpiece and basal region (neck)
in a small percentage of sperm cells. In mouse sperm, CCR6 was also primarily identified in
the principal piece and neck region of the tail, although a small percentage of sperm cells
showed staining in the acrosomal area (Figure 4A).
Curiously, some human sperm cells did not display detectable CCR6 signal. In examining
this issue further, it appeared that the detectability of CCR6 may be related to the state of
sperm capacitation. To address this in an objective manner, we utilized flow cytometry
analysis of human and mouse sperm before and after capacitation (Figure 3B, Figure 4B). In
sperm from both species and states of capacitation, we found two subpopulations of sperm
that differed in their staining with antibody to CCR6. Following capacitation, the more
intensely labeled sperm became more abundant, suggesting that capacitation causes the
exposure or unmasking of epitopes recognized by the CCR6 antibodies. Thus, the
percentage of sperm showing CCR6 staining may reflect different levels of sperm
maturation. Alternatively, the variability could result from differences in the expression
levels of the protein from cell to cell during spermatogenesis, from contributions by
epididymosomes during transit through the epididymis, or from the mixing with
prostasomes during ejaculation (human only). Immunoblotting analyses confirmed the
presence of CCR6 in mouse and human sperm with the expected molecular weights (Figure
5). Therefore, the chemokine receptor CCR6 was present mainly in the tail of sperm cells,
where it may play a role in sperm motility as a chemokine sensor.
CCR6 ligands alter sperm motility patterns and promote chemotaxis
CASA demonstrated that the number of sperm showing kinetic parameters related to
progressive motility (VSL and VAP) was higher after CCL20 treatment compared to the rest
of the treatments (FF and β-defensins) (Figure 6). Moreover, maximal chemotactic
responsiveness was observed with CCL20. CASA analysis showed that the percentage of
cells with a progressive motility pattern also increased after CCL20 treatment. In FF treated
cells, the percentage showing a linear swimming pattern decreased, whereas the percentage
of hyperactivated sperm increased. On the other hand, motility pattern changes were
negligible after treatment with DEFB4 and DEFB103A (also known as DEFB2 and
DEFB3), both of which are known ligands of CCR6, although these are considered weaker
than CCL20 (Ghannam et al., 2011; Yang et al., 1999) (Figure 7). Therefore, CCR6-
displaying sperm cells increase their motility in response to the CCR6-specific chemokine
ligand CCL20, demonstrating that CCR6 is functional in sperm and may also respond to
CCL20 in fluids from the male and/or female genital tracts.
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Discussion
Before fertilization, sperm must receive and process environmental signals to locate the
oocyte (Yanagimachi, 1994). Experiments performed in sea urchin and in other marine
species (Guerrero et al., 2010; Kaupp et al., 2003), demonstrated that these chemoattractants
originate from the oocyte and its surrounding investments (Sun et al., 2005). In addition,
seminal plasma is not just a carrier for spermatozoa. It contains high concentrations of
cytokines, chemokines, and other biological compounds that are able to exert potent effects
on the immune system of the receptive partner (Robertson et al., 2006; Sharkey et al., 2012).
Previous studies have shown that semen induces an acute inflammatory response at the
female genital mucosa after coitus in mammals (for review Robertson et al. (2007),
including humans (Sharkey et al., 2012). The interactions of the sperm with these
chemoattractants primarily influence sperm movement, directing the sperm to the site of
fertilization.
Potential chemoatractant molecules (chemokines and β-defensins) also arise from the
reproductive tract, as shown in the present study. Chemokines are involved in several human
reproductive events (García-Velasco and Arici, 1999; Simón et al., 1998), including
regulatory mechanisms that allow the embryo to grow and develop in the uterus (Caballero-
Campo et al., 2002; Dominguez et al., 2003), and also sperm chemotaxis (reviewed by
Eisenbach and Giojalas (2006)). Although β-defensins have been described in association
with sperm, the function of the β-chemokine receptor CCR6 and its specific ligand CCL20
have never been characterized in sperm, normal reproductive tissues, or genital tract fluids.
In the present study, we found that Ccr6 mRNA is expressed in the mouse testis, and the
protein was located on the plasma membrane of mouse and human sperm. These results
were confirmed by immunoblotting analyses. We believe that the majority of CCR6 in
human and mouse sperm originate in the spermatogenic cells based upon our RNA
expression studies (Figure 2) and data available at the Mammalian Reproductive Genetics
website at the University of Washington [http://mrg.genetics.washington.edu/index.cgi?
mrg_id=328109] although it is formally possible that that some CCR6 is contributed to the
sperm by epididymosomes (Sullivan et al., 2007). In both species, the receptor was primarily
localized to the principal piece of the tail, which represents the first evidence for the
presence of CCR6 on the surface of human and mouse spermatozoa. This region is involved
in motility and hyperactivation, a specialized motility pattern associated with capacitation
(Suarez, 1996). Moreover, using flow cytometry with non-capacitated and capacitated
sperm, we determined that the ability of the anti-CCR6 antibody to detect the protein was
dependent on the capacitation state of the sperm. In studies with other cytokine receptors,
such as CX3CR1, only half of the sperm population was found positive for the receptor
(Zhang et al., 2004). Based on this prevalence, it was suggested that chemokine receptor cell
surface levels vary according to receptor endocytosis and recycling (Oppermann, 2004).
However, we propose that chemokine receptor detection on the sperm surface may actually
be dependent upon the capacitation state of the individual sperm cell.
With demonstration of the presence of CCR6 on the surface of human and mouse sperm, we
next looked at whether ligands for this receptor were expressed in the male and female
reproductive tract fluids. We found the CCR6-specific ligand CCL20 in human seminal
plasma, endometrial fluid, and follicular fluid. As previously described, other chemokines
such as CX3CL1, CXCL8, CCL5, and CCL2 were also detected in these reproductive fluids
(Caballero-Campo et al., 2002; García-Velasco and Arici, 1999; Isobe et al., 2002; Kawano
et al., 2001; Zeyneloglu et al., 1998; Zhang et al., 2004). Seeking to identify the presence of
alternative CCR6 ligands in mouse reproductive tissues, we focused on mouse DEFB29,
which is the β-defensin with the clearest human counterpart in terms of sequence similarity
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(DEFB116). DEFB29 is a proven CCR6 ligand (Conejo-Garcia et al., 2004) and the
expression patterns of either mouse DEFB29 or human DEFB116 (human counterpart) were
previously completely unknown. As shown in this study, we now know that the mRNA
encoding mouse DEFB29 is very highly expressed in the cauda epididymis.
The β-defensins have been mostly described in the male (Patil et al., 2005), but they are also
found in the female genital tract (Quayle et al., 1998; Valore et al., 1998). In the female
mouse endometrium, β-defensins are regulated by estradiol (Soboll et al., 2006). In addition,
the expression of β-defensins in the human endometrium varies in relation to the stage of the
menstrual cycle (King et al., 2003). This is similar to what we have previously seen with
chemokines (Caballero-Campo et al., 2002). This suggests a common regulatory role for
these molecules in reproductive tract maintenance, host defense, and also fertility (García et
al., 2001; Yudin et al., 2005). It is possible that chemokines and β-defensins modulate
sperm–oocyte or sperm–reproductive tract interactions as well as sperm motility (Eisenbach
and Giojalas, 2006; Tollner et al., 2008a, 2008b, 2012). Moreover, mutations in certain
human β-defensins may cause impaired sperm function and subfertility (Tollner et al.,
2011). In particular, we hypothesized that these molecules play a role in sperm physiology
while protecting the male reproductive tract from invading microbial pathogens. In addition,
we demonstrated that CCR6 specific ligands were relevant for sperm motility and sperm-egg
interactions, unveiling their potential contribution to the pre-fertilization processes. We
employed the previously described directionality-based assay (videomicroscopy in a
Zigmond chamber) for sperm chemotaxis (Fabro et al., 2002; Zigmond, 1977) and CASA
analysis of sperm motility parameters (Caballero-Campo et al., 2006). Capacitated sperm
were treated with human follicular fluid and the recombinant CCR6 specific ligands (CCL20
and β-defensins). Furthermore, human FF was used as a source of substances secreted from
the egg and its surrounding cells, including CCL20 as shown in this study. We found that
capacitated cells respond chemotactically to a gradient of human FF, which is in agreement
with earlier studies (Fabro et al., 2002; Giojalas and Rovasio, 1998; Ralt et al., 1991). These
investigations also described the independence of chemotactic responsiveness from other
kinetic behaviors (chemotaxis versus chemokinesis), such as hyperactivation, due to the
presence of progesterone in FF (Jaiswal et al., 1999; Mbizvo et al., 1990). Significantly, the
chemotactic response was more intense to CCL20 compared to FF, exhibiting an increase in
the number of progressively motile sperm and illustrating the absence of an effect on
hyperactivation. In future studies, the effects of CCL20 on motion of hyperactivated sperm
should be more thoroughly studied in light of recent observations suggesting that
hyperactivation is part of the chemotactic response (Armon and Eisenbach, 2011).
Human β-defensins use the same receptor (CCR6) as does the chemokine CCL20,
suggesting that these proteins share similar structural features and, possibly, an analogous
mechanism of receptor recognition and activation. Comparison of the structures of both
human and murine β-defensins with human and murine CCL20 indicated a single aspartate
(Asp 1 in human DEFB1), followed by the hydrophobic residue Tyr3 or Val6 (DHYNCV
motif in human DEFB1), as a potentially important determinant of CCR6-mediated
chemotactic activity of defensin. The DHYNCV fragment is equivalent to the DCCL motif
in CCL20, and in human DEFB1(Hoover et al., 2002; Pérez-Cañadillas et al., 2001;
Rodríguez-Jiménez et al., 2003). These proteins chemoattract and regulate dendritic cells
through binding the CCR6 receptor (Yang et al., 1999). Recently, mononuclear phagocytes
with properties similar to dendritic cells have been located in a dense network at the base of
the epididymal epithelium in the mouse (Da Silva et al., 2011).
CCR6 characterization experiments were performed using an antipeptide antibody. The
region used as an antigen corresponds to amino acid residues 18-46 of human CCR6, and
the antibody also cross-reacts with the mouse orthologue. CCR6–deficient mice appear to be
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healthy and breed well (Cook et al., 2000; Varona et al., 2001). However, as far as we know,
no specific studies on reproduction and sperm function have been reported. Multiple
sequence alignments with other chemokine receptor sequences showed approximately 38%
amino acid identity with the α-chemokine receptors hCXCR1 and hCXCR2, which
represents only slightly more identity than the closest β-chemokine receptor hCCR4, which
is approximately 36% identical (Greaves et al., 1997). The similarity between the human
and murine CCR6 sequences is 73.8% over the entire sequence (Varona et al., 1998).
However, hDEFB4 and hDEFB103A, together with their mouse orthologues (mDEFB4 and
mDEFB14), are chemotactic for a broad spectrum of leukocytes in a CCR6– and, also,
CCR2–dependent manner (Röhrl et al., 2010a). Expression of several chemokine receptors
in sperm has been previously reported (Muciaccia et al., 2005; Zhang et al., 2004;
Zuccarello et al., 2011). Taken together, our results suggest that β-defensins and chemokines
present in reproductive fluids may modulate sperm movement through interaction with their
cognate receptors in the membrane of the sperm cells.
Functional experiments with capacitated human sperm in the present study indicated that
CCR6 and specific ligands might be involved in motility changes related to the capacitation
process, especially kinetic alterations and chemotaxis. Thus, the CCR6 location in sperm
might potentially identify capacitated sperm subpopulations (Eisenbach, 1999). Considering
that receptors for progesterone and mannose identify a subset of sperm (Aitken, 1994;
Benoff et al., 1993), it might be possible that functionally viable sperm express receptors,
e.g., CCR6 or other G-protein coupled receptors such as olfactory receptors (Spehr et al.,
2003).
The interaction of motile human sperm with the oocyte represents a series of integrated
processes designed to deliver sperm with optimal fertilizing potential to the site of
fertilization. These functions may be extremely significant from a medical standpoint.
Determining the prevalence of these factors in fertile and infertile patients might provide
relevant clinical information about certain mechanisms of male reproductive function and
dysfunction. More importantly, these molecules could play a role in the etiology of
idiopathic immunological infertility and may provide tools for its specific diagnosis and
possible treatment. In addition, these mechanisms may expose new targets for contraceptive
interventions. Ongoing studies will elucidate the molecular signaling pathways associated
with these receptors in human and mouse sperm.
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Figure 1.
Human cytokine antibody arrays detected the presence of several chemokines in male and
female reproductive tract fluids. Each membrane contained three or more duplicate negative
controls, which generated background signals, and three positive controls against which all
signals were normalized. The remaining dots corresponded to the 42 or 38 cytokines/
chemokines in duplicate. Seminal plasma, endometrial fluid and follicular fluid exhibited the
specific CCR6 ligand CCL20. In addition, CXCL8, RANTES, Fraktalkine, SDF1, and
IGF-1 were also found. These are ligands and receptors that have been reported to be
involved in sperm motility (see text).
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Figure 2.
As detected by quantitative real-time PCR analysis, Defb29 and Ccr6 mRNAs were
expressed in the mouse male reproductive tract. A. Defb29 in the cauda epididymis was very
highly expressed relative to different tissues. Levels were about 3 times higher than kidney
and over 20-25 times higher than found for peritoneum. Most other tissues expressed
Defb29 at much lower but detectable levels. B. Ccr6 mRNA was highly expressed in testis,
lung, colon, and dendritic cells (positive control).
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Figure 3.
CCR6 is localized mainly in the flagellum of human sperm. A. Indirect immunofluorescence
revealed two different patterns of localization of CCR6 in human sperm. The fluorescence
signal was mainly in the tail (principal piece), whereas few sperm showed staining in the
midpiece and basal region (neck) area. This localization was not found in the complete
sperm population. Photographs above correspond to paired brightfield images. Sperm
incubated without first antibody in 10% normal goat serum displayed negligible staining,
and white blood cells were used as a positive control (data not shown). B. Flow Cytometry
analysis was performed to quantify the amount of CCR6 on the surfaces of individual sperm
cells. The protein was not detected in every sperm. The distribution of fluorescence emission
intensity identified two different subpopulations in human sperm. Importantly, capacitating
conditions increased the percentage of sperm cells positive for CCR6.
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Figure 4.
Mouse sperm CCR6 is found principally in the flagellum. A. Indirect immunofluorescence
for mouse cauda epididymal sperm showed two different patterns of localization for the
chemokine receptor CCR6. Localization in mouse sperm from cauda epididymis was mainly
restricted to the principal piece of the tail and neck, although a few sperm showed staining in
the acrosomal area. Photographs above correspond to paired brightfield images. B.
Capacitating conditions did not increase the percentage of mouse sperm positive cells for
CCR6, as determined by flow cytometry.
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Figure 5.
CCR6 was present in human and mouse sperm as determined by immunoblotting. In human
(lane 2) and mouse (lane 3) sperm extracts. The anti-peptide CCR6 antibody identified an
immunoreactive band with a molecular weight of approximately ~50,000 Mr) (expected
molecular weight ~42,000 Mr). Depending on the experimental conditions, other minor
bands were also recognized by this antibody, suggesting that the protein may undergo post-
translational modification. Mouse spleen extracts (lane 1) and human white blood cells (not
shown) served as positive controls for the detection of CCR6.
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Figure 6.
Effect of CCR6 ligands (CCL20, DEFB4 [also known DEFB2], DEFB113A [DEFB4]) on
CASA frequency distribution of motility parameters. After CCL20 treatment, CASA
detected an increase in the number of sperm with high values of the progressive (i.e., linear)
motility parameters VAP (average path velocity) and VSL (straight line velocity). FF
treatment elicited a greater number of sperm with high values of the non-progressive
parameters curvilinear velocity (VCL > 120 μm/sec) and amplitude of lateral head
displacement (ALH > 6 μm), which characterized the hyperactivated pattern (Burkman,
1991). (n=4 independent experiments).
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Figure 7.
Sperm motility evaluation in response to CCL20 showed changes in the progressive rapid
pattern and evidence of chemotaxis. A. The percentage of spermatozoa showing a
hyperactivated pattern is higher after FF treatment compared to HTF (control). No
statistically significant differences were found after CCR6 ligand treatments (CCL20,
DEFB4 [DEFB2], DEFB113A). B. Percentage analysis after CCL20 showed an increase in
the percentage of spermatozoa with progressive rapid motility. C. The percentage of cells
showing a chemotactic response was higher in the CCL20 treatment than control HTF. (n=4
independent experiments, statistically significant p<0.05).
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Table 1
Semi-Quantitative Analysis of Chemokines in Reproductive Fluids and Receptors in Mammalian Sperm
Seminal Plasma Endometrial Fluid Follicular Fluid
IL-8 +++ ++ ++
CCL2/MCP-1 +++ ++ +++
CCL5/Rantes - - +++
CXC3CL1/Fraktalkine ++ ++ ++
CCL20/MIP-3α ++ + ++
The relative expression levels in protein arrays ranged from no detectable amounts (−) to intensely positive (+++). Positive controls were used to
validate the results from different membranes. Results are representative from at least three different samples.
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